<DOC>
	<DOCNO>NCT01201928</DOCNO>
	<brief_summary>The purpose study evaluate pulmonary function test ( PFT ) sub-study interested subject study MKC-TI-161 , MKC-TI-162 MKC-TI-166 . 100 Type I 100 Type II diabetic enrol . Each subject undergo 6 PFT assessment course parent study .</brief_summary>
	<brief_title>Pulmonary Function Substudy Subjects Enrolled Studies MKC-TI-161 , MKC-TI-162 MKC-TI-166</brief_title>
	<detailed_description>This study design evaluate compare change pulmonary function ( FEV1 ( forced expiratory volume 1 second ) FVC ( force vital capacity ) , TLC ( total lung capacity ) DLco ) subject enrolled 1 3 parent trial ( MKC-TI-161 , MKC-TI-162 MKC-TI-166 ) . Up 100 subject Type I Type II diabetes TI Inhalation Powder arm , 100 subject Type I Type II diabetes comparator arm enrol . Each subject undergo 6 PFT assessment course parent trial .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Enrollment one three parent trial ( MKCTI161 , MKCTI162 MKCTI166 ) Subjects unable perform PFTs meet American Thoracic Society/European Respiratory Society ( ATS/ERS ) quality recommendation acceptability repeatability exclude study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2012</verification_date>
</DOC>